Skip to content

Effect of Mandala Practice on Menopausal Symptoms and Quality of Life

Effect of Mandala Practice on Menopausal Symptoms and Quality of Life

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07149285
Enrollment
78
Registered
2025-08-29
Start date
2025-09-30
Completion date
2025-10-31
Last updated
2025-08-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Menopausal Symptoms, Menopause Symptom Management, Quality of Life

Keywords

menopause, mandala painting, menopausal symptoms, quality of life, nursing

Brief summary

Menopause is a natural cycle of life that mostly develops due to changes in the endocrine glands of the female body during middle age, and the menstrual cycle is permanently interrupted as a result of the ovaries losing their activity. Many symptoms are observed in women during menopause, and these symptoms cause women to experience many physiological, mental, social and sexual problems in the short or long term and to deteriorate their quality of life. In reducing the menopause symptoms experienced by women, hormone replacement therapy, traditional methods, mental or physical applications; aromatherapy, hypnosis, Biofeedback and relaxation techniques are used. The aim of these applications; is to relax women, reduce menopausal symptoms and increase their quality of life. Mandala, which has been widely used in the field of therapy in the past and today, is seen as a meditation tool in art therapy and is defined as a complementary, safe and accessible activity that supports mental health. It has been determined that how the mandala method, which is used in many areas in the literature, affects the symptoms and quality of life of women in the menopausal period has not been examined. For this reason, it is thought that this study will make a significant contribution to the literature.

Detailed description

This study was designed as a randomized controlled experimental trial to examine the effects of mandala practice on menopausal symptoms and quality of life. The study will be conducted with 78 women (experimental = 39, control = 39) diagnosed with menopause at the Private Palmiye Hospital Gynecology and Obstetrics Outpatient Clinics. Participants will be randomly assigned to groups via random.org. Women in the experimental group will practice mandala coloring for 20-30 minutes daily for 15 days, while the control group will only be administered the scales and will be advised to practice mandala practice at the end of the study due to ethical principles. Data will be collected using a Personal Information Form, the Menopause Symptoms Assessment Scale, the Menopause-Specific Quality of Life Scale, and the Mandala Practice Follow-up Form. Data will be analyzed using frequency, descriptive statistics, the Shapiro-Wilks normality test, the independent samples t-test, one-way analysis of variance, and the Pearson correlation test in SPSS 24.0. It is anticipated that the findings of the study will make a significant contribution to the literature by revealing the effect of mandala practice in reducing symptoms and improving quality of life in menopausal women.

Interventions

OTHERMandala coloring

Intervention Group: The content of the study and the mandala application will be explained to women diagnosed with menopause, and after obtaining consent, a personal information form and scales regarding menopause symptoms and quality of life will be applied. Participants will be given a sample and blank mandala, 12 colored crayons and a follow-up form. The mandala application will be done for 20-30 minutes every day for 15 days, and will be monitored by phone every other day. At the end of the process, the scales will be re-applied and the follow-up forms will be collected. Their routine treatments will continue.

Sponsors

Emine Karacan
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

Participants will not know which group (experimental or control) they are included in or the effectiveness of the method applied to the experimental group. The researchers implementing the intervention will not be involved in the data analysis phase; data analysis will be conducted by independent researchers who are unaware of the groups.

Intervention model description

Intervention Group: The content of the study and the mandala application will be explained to women diagnosed with menopause, and after obtaining consent, a personal information form and scales regarding menopause symptoms and quality of life will be applied (Pre-test). Then, participants will be given a sample and blank mandala, 12 colored crayons and a follow-up form. The mandala application will be done for 20-30 minutes every day for 15 days, and will be monitored by phone every other day. At the end of the process, the scales will be re-applied (post-test) and the follow-up forms will be collected. Control Group: After the participants are informed about the study and their consent is obtained, the same scales will be applied (Pre-test). They will be interviewed again 15 days later and the scales will be filled out again (Post-test). Mandalas and pencils will be given to those who want them at the end of the study for ethical reasons.

Eligibility

Sex/Gender
FEMALE
Age
40 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

1. The study included women who met the following conditions: 2. Absence of cognitive, hearing, or speech impairments that could interfere with effective communication, 3. No physical, psychological, or visual limitations that could hinder participation in mandala coloring activities, 4. Literacy in Turkish, including the ability to read, comprehend, and write, 5. A confirmed medical diagnosis of menopause, 6. Not undergoing any form of psychotherapy or alternative treatment throughout the study period, 7. Voluntary participation with signed informed consent.

Exclusion criteria

1. Participants were excluded from the study if they: 2. Provided incomplete or inaccurate responses in the data collection forms, 3. Were receiving hormone therapy to manage menopausal symptoms, 4. Had a neurological disorder that could impair concentration or communication during the mandala activity, 5. Had known allergies to paints or similar substances.

Design outcomes

Primary

MeasureTime frameDescription
Menopausal Symptoms Assessment Scale (MSAS) total scorePre-intervention (day 0) and post-intervention (day 15)Evaluation of the effect of mandala practice on the severity of somatic, psychological and urogenital symptoms in menopausal women. The MSAS consists of 11 items and three subscales. The subscales are labeled Somatic Complaints, Psychological Complaints, and Urogenital Complaints. The scale is answered on a 5-point Likert-type scale, with each item scored as follows: 0: None, 1: Mild, 2: Moderate, 3: Severe, and 4: Extremely severe. The lowest possible score for the entire scale is 0, and the highest is 44. A higher total score indicates an increase in the severity of the complaints and a negative impact on quality of life.

Secondary

MeasureTime frameDescription
Menopause-Specific Quality of Life Scale (MSQL) total and sub-dimension scoresPre-intervention (day 0) and post-intervention (day 15)Evaluation of the effect of mandala practice on the quality of life (vasomotor, psychosocial, physical and sexual dimensions) of menopausal women. The scale consists of four domains: vasomotor, psychosocial, physical, and sexual. It contains 29 Likert-type statements. As the score increases, the severity of the complaint and the quality of life decrease. Because the total scale uses an average score, the lowest possible score is 0, and the highest is 6. Each subdomain on the MSQL is scored from 0 to 6. A score of 0 indicates that no problem is experienced. A score of 1 indicates that the problem exists, but it is not bothersome at all. Scores between 2 and 6 indicate the severity and increasing severity of the problem.

Countries

Turkey (Türkiye)

Contacts

Primary ContactEmine Karacan, Asst Prof
emine.karacan@gibtu.edu.tr+90 537 214 83 75
Backup ContactEmine Karacan, Asst Prof
emine.karacan@iste.edu.tr+90 5300350414

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026